A series of N,N-substituted ethylene-1,2-diamine derivatives have been prepared from reaction of 2-hydroxybenzaldehyde derivatives and 1,2-diamine derivatives in the presence of NaBH 4 through Schiff base intermediate. The synthesized compounds were screened for their antibacterial activities. Compound SB01, SB02 and SB09 displayed significant activity at MIC ranges from 0.40-6.25 µg/mL.
INTRODUCTION
Schiff bases are synthesized typically by the condensation reaction of a primary amine and an aldehyde/ketone. The resultant compound, R1R2C=NR3 is called a Schiff base, where R1 is an aryl or alkyl group, R2 is a hydrogen atom and R3 is either an alkyl or aryl group. The ary substituted Schiff bases are considerably more stable and easily prepared, while Schiff bases with alkyl substituents are comparatively less stable 1 , while those of aromatic aldehydes having effective conjugation are more stable. In general, aldehydes are more reactive than ketones in condensation reactions, leading to the formation of Schiff bases as the reaction center of aldehydes are sterically less hindered than that of ketone. Moreover, the extra carbon of ketone releases more electron density to the azomethine carbon and therefore makes the ketone less electrophilic as compared to aldehydes 2 
.
Schiff base derivatives have a wide variety of applications in pharmaceutical, analytical chemistry [3] [4] . Transition metal complexes of Schiff bases have extremely significant comprising enormous areas of coordination compounds 5 . The synthesis of symmetrical Schiff bases obtained from reaction of carbonyl compounds, with substituted diamines in the ratio 1:2 and various aldehyde/ketone derivatives. Recently large amount of effort has been taken for the preparation and identification of different coordination complexes of Schiff base ligands 6 . Schiff base ligands are important in the studies of coordination complexes since they essentially produce stable complexes 7 . Schiff base reactions are significant in organic reactions for preparing carbon-nitrogen bonds. Schiff bases have often known to form chelates type complexes. The suitabely positioned heteroatoms like O, N and S are key atoms in the formation of coordination complexes in the structures of various metallobiomolecules 8 . This class of compounds have been widely studied for their antiviral, antifungal, anticancer, antibacterial and herbicidal activities [9] [10] [11] . It is common that the incorporation of metal ions to structure of biologically important compounds may improve their potencies.
The salophens exhibit flexible electronic, steric and lipophilic nature. These type of componds can be easily synthesized by the reaction of o-hydroxybenzaldehyde and 1,2-diamines. Salophen compounds with nitrogen and oxygen atoms are significant as their metal complexes show broad range of applications in a variety of reactions as homogeneous catalysis [12] [13] , Oxidation 14 , hydroxylation 15 , Epoxidation 16 , Polymerization 17 , Hydrogenation 18 . These compounds also found applications as electroluminescent materials [19] [20] , optical devices 21 , electrochemical sensors 22 , antifungal 23 and antimicrobial activity 24 .
Generally Schiff bases have tendence to under go hydrolysis in solution phase. This problem overcome by reducing the imine bond by using common and mild reducing agent like Sodium borohydride. This could improve properties of the the reduced Schiff base and the resultant compound could be more flexible and non-planar while coordinating to a metal ion [25] [26] .
Recently it is reported that reduced Schiff base derivative showed significant antimicrobial activity at low concentration level 27 . Voronova et al., 28 reported excellent catalyst for the Sonogashira coupling reaction. Further, various types of reduced Schiff base ligands and their Iorn centered complexes have gained mored attraction in the field of medicinal chemistry due to their effective DNA cleavage activity 29 . It is evident from the literature that partially reduced Schiff base moieties are known to show excellent catalyst for oxidation of various phenols 30 
Based on above observation and in extension of our research work for finding better antimicrobial copunds [31] [32] [33] [34] [35] [36] we found that it was worth trying to synthesize various reduced Schiff bases derivatives with expected antibacterial activity.
EXPERIMENTAL

General procedure for preparation of schiff bases
A solution of aldehyde derivative (4 mmol) and 1, 2-diamine derivative 1a-1c (2.0 mmol) in EtOH (8 mL) maintained for 2 h at 70 0 C under stirring. Reaction completion monitored with TLC. Reaction mass cooled to room temperature and the solid obtained was filtered and dried. 
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Biological evaluation Anti-mycobacterial activity
The anti-microbial activities of the newly prepared compounds evaluated against M. tuberculosis ATCC No-27294 by microplate Alamar Blue assay (MABA). A blue colour in the well was indicates bacterial growth whereas pink colour show growth of bacteria.
RESULTS AND DISCUSSIONS
Chemistry
The target compounds RSB01-RSB09 were prepared as outlined in Fig. 1 . The required Schiff bases (SB01-SB09) were obtained by condensation reaction of requisite aldehydes and amines. The compounds (RSB01-RSB09) were prepared by reduction of imine bond of compounds with reducing agent like NaBH 4 in quantitative yield. Elemental analysis and spectral data (FTIR, 1 H and 13 C-NMR, MS) confirmed the structure of the synthesized products. The IR spectrum of Schiff bases SB01-SB09 showed strong absorption bands at 1614-1616 cm -1 and 3100-3400 cm -1 due to imine (-HC=N-) function and hydroxyl (-OH) group respectively, The 1 H-NMR spectrum of Schiff bases SB01-SB09 revealed, in addition to expected aromatic signals, three singlets at δ 8.91 and 12.95 ppm are assignable to the azomethine proton (-CH=N-) and hydroxyl proton (-OH), respectively. In addition, the 13 C-NMR spectrum of Schiff bases SB01-SB03 displayed typical peaks at δ 161.0-161.5 ppm assignable to imine carbon. Moreover the mass spectrum of Schiff bases revealed molecular ion peak confirming corresponding molecular weight of target compounds.
The FTIR spectra of reduced Schiff base RSB02 showed broad peak in the region 3289-3394 cm -1 due to amino (-NH-) and hydroxyl group, respectively. The 1 H-NMR spectrum of reduced Schiff bases RSB02 showed, in addition to expected aromatic signals, three singlets at δ 5.03 and 13.33 ppm are assignable to the amino (-NH-) and hydroxyl proton (-OH), respectively. The singlet at δ 4.2 due to -CH 2 -group confirms the formation of reduced Schiff bases. Additionally the mass spectrum of reduced Schiff base RSB02 revealed molecular ion peak at m/z 320.13 confirming it's molecular weight of target compound. Similarly other reduced Schiff bases have been characterized. 
Anti-mycobacterial activity
The anti-mycobacterial effects of the schiff base derivatives compounds SB01-SB09 and RSB01-RSB09 against Mycobacterium tuberculosis. The Ciprofloxacin (MIC 3.12 mg/mL), Pyrazinamide (MIC 3.12 mg/mL) and Streptomycin (MIC 6.25 mg/mL) were used as references to compare the potency of the synthesized compounds. As shown in table 3 compounds SB01 has unpredictable high anti-tuberculosis activity against Mycobacterium tuberculosis as its MIC value is 12.50 µg/mL. This could be due to formation a specific complex with cell wall protein and ultimately interfering in cell wall synthesis of Mycobacterium tuberculosis during cell mitosis phase of multiplication. The presence of active pharmacophore present in the molecular structure of the compound, like imine double bond between carbon and nitrogen and well positioned hydroxyl group, these structural units restrict in the mechanism of cell multiplication and hence stop further growth of M. tuberculosis. All the samples under study are diplaying different activity because of the effective barrier of an outer cell wall membrane of M. tuberculosis for entry of external compounds.
This outcome indicates that suitably placed pharmacophores improved the penetration into the cell wall of the M. tuberculosis, which translated into good activity. In addition, these compounds interfere the respiration process of the cell and thereby stop the synthesis of proteins. If the synthesis of proteins is inhibited then formation bacterial cell wall is not possible which ultimately results in cell death and therefore restricts further growth and infection of the bacteria.
The results of anti-mycobacterial activity of all compounds SB01-SB09 and RSB01-RSB09 is shown in Table 3 . The compound RSB01-RSB09 showed poor activity as compared to SB01-SB09 suggesting that the imine moiety was important to activity. Clearly, the presence of Schiff base moiety is crucial for anti-tubercular activity.
Antibacterial activity
Ciprofloxacin was used as references to evaluate the potency of the synthesized compounds against Escherichia coli (MIC 2.00 mg/mL), Pseudomonas aeruginosa (MIC <4.00 mg/mL), staphylococcus aureus (MIC 2.00 mg/mL), bacillus subtilis (MIC 2.00 mg/mL). The compounds SB01-SB09 showed excellent antibacterial antibacterial activity as compared to their reduced forms RSB01-RSB09. This also predicts the importance of the imine bond for the antibacterial activity.
CONCLUSION
In conclusion, the synthesis of 18 compounds were easily performed with good yields. All compounds were tested against M. tuberculosis, E. coli, P. aeruginosa, S. aureus, B. subtilis three of them (SB01, SB02 and SB09) exhibit considerable activity when compared with standard drugs like Ciprofloxacin, Pyrazinamide and Streptomycin.
